Celyad Oncology SA · EURONEXT:CYAD

Celyad Oncology SA — Fact Sheet (June 2022)

1 slide from Celyad Oncology SA's fact sheet, June 2022

  1. Slide 1: Allogeneic Non Gene-Edited shRNA Platform

    Allogeneic Non Gene-Edited shRNA Platform The ability to control gene expression and optimize function of CAR T cells is essential in order to expand application of CAR T therapies to a wider range of cancers Short hairpin RNA (shRNA) is a small piece of RNA that can decrease gene expression, effect

Celyad Oncology — Fact Sheet (June 2022) on 6ix